## 品質ゲート評価

**⚠️ 重要: 各項目に対して明示的にPASS/FAILを判定してください。1つでもFAILがあれば最終判定は自動的にFAILです。**

- [x/  ] **実装戦略の判断根拠が明記されている**: **PASS** - `design.md:8-24` clearly states EXTEND with rationale tied to existing YAML components and Pulumi logic, so the extension approach is justified.  
- [x/  ] **テスト戦略の判断根拠が明記されている**: **PASS** - `design.md:14-24` explains why INTEGRATION_ONLY tests are the focus and why extending existing Translator-validation steps satisfies EXTEND_TEST.  
- [x/  ] **既存コードへの影響範囲が分析されている**: **PASS** - `design.md:26-29` explicitly enumerates the component YAMLs and Pulumi index.ts, plus dependencies/migration scope, so impact is documented.  
- [x/  ] **変更が必要なファイルがリストアップされている**: **PASS** - `design.md:31-38` lists the new template file plus each touched YAML/TS file, providing concrete paths.  
- [x/  ] **設計が実装可能である**: **PASS** - `design.md:40-89` walks through template format, Pulumi integration, validation steps, monitoring ops, and ordered implementation steps, showing a feasible path.

**品質ゲート総合判定: PASS**

## 詳細レビュー

### 1. 戦略判断の妥当性

**良好な点**:
- `design.md:8-24` aligns the EXTEND strategy tightly with the existing ARM/x86 components and Pulumi template flow, providing a convincing justification without inventing new subsystems.
- `design.md:14-24` links the INTEGRATION_ONLY and EXTEND_TEST choices to Translator+Pulumi previews, demonstrating awareness of the configuration-heavy nature of the change.

**懸念点**:
- None; the rationale is coherent and connects to the requirements.

### 2. 影響範囲分析の適切性

**良好な点**:
- `design.md:26-29` lists the exact files and clarifies there are no new service dependencies or schema migrations, so the impact scope is scoped.

**懸念点**:
- None.

### 3. ファイルリストの完全性

**良好な点**:
- `design.md:31-38` names the new template plus each modified component, satisfying the requirement for explicit paths.

**懸念点**:
- None.

### 4. 設計の実装可能性

**良好な点**:
- `design.md:40-89` details the template structure, Pulumi replacement logic, Translator invocation, diff checks, docs, and implementation order, giving implementers a clear sequence.

**懸念点**:
- None.

### 5. 要件との対応

**良好な点**:
- `design.md:65-70` maps each FR/AC to design elements (metric definitions, template reuse, Translator steps, preview/diff checks, docs) providing strong traceability.

**懸念点**:
- None.

### 6. セキュリティ考慮

**良好な点**:
- `design.md:72-75` ensures only `AutoScalingGroupName` appears, reuses existing IAM scope, and avoids secrets in templates/logs.

**改善の余地**:
- Consider specifying how template files are validated before commit (e.g., format linting) to avoid accidental inclusion of sensitive data, though risk is low.

### 7. 非機能要件への対応

**良好な点**:
- `design.md:78-81` addresses cost (60s interval, single dimension), scalability (template reuse across ASGs), and maintainability (Pulumi replace logic, documented validation).

**改善の余地**:
- None.

## ブロッカー（BLOCKER）

**次フェーズに進めない重大な問題**

なし

## 改善提案（SUGGESTION）

1. **Diff-validation automation**
   - 現状: `design.md:57-59` mentions adding a simple comparison script for ARM/x86 blocks but stops short of specifying how it’s triggered.
   - 提案: Tie the diff check into the Pulumi preview or CI job with pass/fail criteria (e.g., `diff` exit code) so regressions are caught before AMI builds.
   - 効果: Prevents future divergence between architectures by automating detection.

## 総合評価

**主な強み**:
- Strategy/test justification clearly reference existing workflows and the necessary integration points (`design.md:8-24`).
- Impact and file lists are explicit, and implementation steps (template → Pulumi → components → validation → docs) are sequentially actionable (`design.md:31-89`).
- Security and non-functional considerations are addressed, keeping costs and maintainability in check (`design.md:72-81`).

**主な改善提案**:
- Automate the ARM/x86 diff check within CI/preview to fail fast when the shared template drifts (`design.md:57-59`).

（Phase 2のPlanningチェックリストについて、共通テンプレート設計と検証手順設計のタスクを完了として`planning.md`にマークしました）

**判定: PASS**

---

Next steps: implement the template + Pulumi replacements, hook the diff check into CI, and update docs/monitoring playbooks as outlined.